Stockscreener 앱 받기
0.385
4.21%
-0.0169
시간 외 거래:
.36
-0.025
-6.49%
Lunai Bioworks Inc 주식(LNAI)의 최신 뉴스
Lunai Bioworks Engages Initial U.S. Countermeasure Opportunities Following $400M–$1.2B Consortium Launch - Weekly Voice
Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model - Finviz
LNAI Initiates Consortium to Speed Up Chemical Countermeasure Development - GuruFocus
Lunai Bioworks (LNAI) Stock Forecast and Price Target 2026 $LNAI - MarketBeat
LNAI stock: Lunai Bioworks (NASDAQ) $0.52, vol 509,735,274 on 17 Mar 2026: monitor AI oncology signals - Meyka
Best Manufacturing Stocks To Watch TodayMarch 17th - MarketBeat
Why Is This Micro-Cap Biotech Stock Up 150% Today? - Asianet Newsable
Why Is LNAI Stock Skyrocketing Today? - Stocktwits
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Lunai Bioworks (LNAI) jumps 189% as traders refocus on recent IP update and looming Nasdaq listing decision - Quiver Quantitative
Lunai Launches AI Safeguard Sentinel to Prevent Chemical Agent Generation - Intellectia AI
ENOB FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class ActionENOB - marketscreener.com
Lunai Bioworks initiates employee furloughs and salary deferrals to preserve liquidity - Investing.com UK
Lunai Bioworks Furloughs Staff Amid Liquidity Constraints - TipRanks
Lunai Bioworks implements temporary furlough of employees in US and CanadaSEC filing - marketscreener.com
Lunai Bioworks implements temporary furloughs, execs defer salaries to preserve liquidity - TradingView
Financial Survey: Lunai Bioworks (NASDAQ:LNAI) versus Lite Strategy (NASDAQ:LITS) - Defense World
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - The Sheboygan Press
Lunai Bioworks Highlights Sentinel AI Safeguard After Anthropic CEO Warning on AI Chemical and Biological Threats - The Destin Log
LNAI Should I Buy - Intellectia AI
Lunai Bioworks Faces Nasdaq Delisting, Hearing Scheduled - TipRanks
Lunai Bioworks Received Notice of Delisting - TradingView
Head-To-Head Comparison: Lunai Bioworks (NASDAQ:LNAI) vs. NexImmune (OTCMKTS:NEXI) - Defense World
LNAI | Lunai Bioworks Inc. Common Institutional Ownership - Quiver Quantitative
LNAI | Lunai Bioworks Inc. Common Insider Trading - Quiver Quantitative
Lunai Bioworks Reports Q2 Loss - National Today
Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping - Finviz
Lunai Bioworks kicks off AI-driven oncology pilot to analyze phase 2 colorectal cancer trial - MSN
Lunai Bioworks: Second Quarter Financial Results Overview - Bitget
Lunai Bioworks: Fiscal Q2 Earnings Snapshot - marketscreener.com
Lunai Bioworks Inc. SEC 10-Q Report - TradingView
Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC - Finviz
Lunai Bioworks Faces Nasdaq Delisting After Bid Price Breach - TipRanks
Lunai Bioworks Launches AI Oncology Pilot to Analyze Phase 2 Colorectal Cancer Trial Data - AIM Media House
Lunai Bioworks Updates Shareholders on February 2026 Operational Progress and Future Plans - geneonline.com
Lunai Bioworks, Inc. Issues Letter to Shareholders - The Malaysian Reserve
LNAI Partners on Phase 2 Cancer Trial to Enhance Patient Outcomes - GuruFocus
LNAI Strengthens AI Platform for Biotech Innovations and Partner - GuruFocus
Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data - Finviz
Lunai Bioworks (Nasdaq LNAI) launches AI oncology pilot - marketscreener.com
Lunai Bioworks (Nasdaq Lnai) Launches Ai Oncology Pilot - TradingView
Lunai Bioworks launches AI analysis of colorectal cancer trial data - Investing.com
Lunai Bioworks Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data - marketscreener.com
Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons - Finviz
Lunai Launches Sentinel AI Biosecurity Layer - Intellectia AI
AI safeguard Sentinel blocks novel chemical weapon designs at source - stocktitan.net
Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery - The Malaysian Reserve
Lunai Bioworks launches alcohol use disorder drug discovery program By Investing.com - Investing.com Canada
Lunai Bioworks Expands NIH-Backed AI Platform Into Commercial Alcohol Use Disorder Drug Discovery - Nasdaq
LNAI Advances Drug Discovery Program for Alcohol Use Disorder - GuruFocus
Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into - GuruFocus
1.20%
0.06%
자본화:
|
볼륨(24시간):